Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Cheng‐Feng Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0632-2807; OpenAlex author ID A5062907814. Sources: OpenAlex.

Their work

Papers
13 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2021: 4 papers · 2022: 3 papers · 2023: 3 papers · 2024: 3 papers

Papers 13

  1. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Co-author DOI 10.1007/s13402-024-00925-x↗
  2. The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy. Co-author DOI 10.1186/s12935-024-03456-5↗
  3. Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer. First author DOI 10.21037/tcr-24-54↗
  4. STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation. Co-author DOI 10.1038/s41419-023-05711-5↗
  5. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway. First author DOI 10.1186/s12967-023-04043-4↗
  6. DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma. First author DOI 10.1371/journal.pgen.1010847↗
  7. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2022.e10416↗
  8. CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. Co-author DOI 10.1186/s12935-022-02768-8↗
  9. Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs. First author DOI 10.1186/s12935-022-02785-7↗
  10. Mobius strip in pancreatic cancer: biogenesis, function and clinical significance of circular RNAs. Co-author DOI 10.1007/s00018-021-03908-5↗
  11. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Co-author DOI 10.1007/s13402-021-00651-8↗
  12. The role of autophagy in pancreatic cancer progression. First author DOI 10.1016/j.bbcan.2021.188592↗
  13. Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.596573↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bangbo Zhao · 12 shared papers, 2021–2024 · strength 2.24
  2. Zeru Li · 11 shared papers, 2021–2024 · strength 2.07
  3. Weibin Wang · 11 shared papers, 2021–2024 · strength 2.04
  4. Yuanyang Wang · 11 shared papers, 2021–2024 · strength 2.00
  5. Xiaoying Yang · 7 shared papers, 2021–2024 · strength 1.19
  6. Tianyu Li · 6 shared papers, 2022–2024 · strength 1.15
  7. Yutong Zhao · 5 shared papers, 2022–2024 · strength 0.99
  8. Tianhao Li · 3 shared papers, 2022 · strength 0.50
  9. Tianhao Li · 3 shared papers, 2021–2024 · strength 0.49
  10. Xingtong Zhou · 2 shared papers, 2021–2024 · strength 0.35
  11. Gang Yang · 2 shared papers, 2021 · strength 0.30
  12. Tianyu Li · 1 shared paper, 2024 · strength 0.24
  13. Weibin Wang · 1 shared paper, 2023 · strength 0.19
  14. Wenhao Luo · 1 shared paper, 2021 · strength 0.12
  15. Fangyu Zhao · 1 shared paper, 2021 · strength 0.12
  16. Jinshou Yang · 1 shared paper, 2021 · strength 0.12
  17. Guangyu Chen · 1 shared paper, 2021 · strength 0.12
  18. Jiangdong Qiu · 1 shared paper, 2021 · strength 0.12
  19. Taiping Zhang · 1 shared paper, 2021 · strength 0.12
  20. Yupei Zhao · 1 shared paper, 2021 · strength 0.12
  21. Lei You · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.